|
|
|
Volumn 23, Issue 6, 1996, Pages 744-753
|
|
Systemic chemotherapy for the treatment of metastatic melanoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
DOCETAXEL;
LOMUSTINE;
MEGESTROL;
TAMOXIFEN;
TEMOZOLOMIDE;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
BLOOD TOXICITY;
BRONCHOSPASM;
CANCER REGRESSION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER VENOOCCLUSIVE DISEASE;
MAJOR CLINICAL STUDY;
MELANOMA;
METASTASIS;
MUCOSA INFLAMMATION;
PRIORITY JOURNAL;
REVIEW;
SKIN MANIFESTATION;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
FEMALE;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
INTERLEUKIN-2;
MALE;
MELANOMA;
|
|
EID: 0030448615
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (37)
|
|
References (0)
|
